- Home
- APGE vs BCRX Comparison
APGE vs BCRX Comparison
Compare APGE & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- BCRX
- Stock Information
- Founded
- APGE 2022
- BCRX 1986
- Country
- APGE United States
- BCRX United States
- Employees
- APGE N/A
- BCRX N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- APGE Health Care
- BCRX Health Care
- Exchange
- APGE Nasdaq
- BCRX Nasdaq
- Market Cap
- APGE 2.0B
- BCRX 1.8B
- IPO Year
- APGE 2023
- BCRX 1994
- Fundamental
- Price
- APGE $37.63
- BCRX $7.70
- Analyst Decision
- APGE Strong Buy
- BCRX Strong Buy
- Analyst Count
- APGE 5
- BCRX 10
- Target Price
- APGE $95.40
- BCRX $16.70
- AVG Volume (30 Days)
- APGE 465.5K
- BCRX 2.2M
- Earning Date
- APGE 11-11-2025
- BCRX 11-03-2025
- Dividend Yield
- APGE N/A
- BCRX N/A
- EPS Growth
- APGE N/A
- BCRX N/A
- EPS
- APGE N/A
- BCRX N/A
- Revenue
- APGE N/A
- BCRX $557,506,000.00
- Revenue This Year
- APGE N/A
- BCRX $41.34
- Revenue Next Year
- APGE N/A
- BCRX $6.11
- P/E Ratio
- APGE N/A
- BCRX N/A
- Revenue Growth
- APGE N/A
- BCRX 45.85
- 52 Week Low
- APGE $26.20
- BCRX $6.02
- 52 Week High
- APGE $63.50
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- APGE 50.77
- BCRX 31.08
- Support Level
- APGE $36.01
- BCRX $7.64
- Resistance Level
- APGE $37.97
- BCRX $8.13
- Average True Range (ATR)
- APGE 1.66
- BCRX 0.22
- MACD
- APGE 0.02
- BCRX -0.05
- Stochastic Oscillator
- APGE 56.28
- BCRX 6.19
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.